Park National Corp’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26M | Sell |
103,283
-2,223
| -2% | -$478K | 0.73% | 41 |
|
|
2026
Q1 | $22.9M | Buy |
105,506
+5,910
| +6% | +$1.31M | 0.7% | 44 |
|
|
2025
Q4 | $22.8M | Sell |
99,596
-10,959
| -10% | -$2.5M | 0.71% | 43 |
|
|
2025
Q3 | $25.6M | Sell |
110,555
-7,072
| -6% | -$1.44M | 0.8% | 40 |
|
|
2025
Q2 | $21.8M | Sell |
117,627
-9,546
| -8% | -$1.77M | 0.72% | 44 |
|
|
2025
Q1 | $26.6M | Sell |
127,173
-9,524
| -7% | -$1.85M | 0.98% | 37 |
|
|
2024
Q4 | $24.3M | Sell |
136,697
-1,937
| -1% | -$356K | 0.89% | 36 |
|
|
2024
Q3 | $27.4M | Sell |
138,634
-7,465
| -5% | -$1.39M | 0.96% | 36 |
|
|
2024
Q2 | $25.1M | Buy |
146,099
+11,673
| +9% | +$1.93M | 0.93% | 36 |
|
|
2024
Q1 | $24.5M | Sell |
134,426
-10,771
| -7% | -$1.86M | 0.94% | 34 |
|
|
2023
Q4 | $22.5M | Sell |
145,197
-6,663
| -4% | -$971K | 0.92% | 36 |
|
|
2023
Q3 | $22.6M | Buy |
151,860
+3,295
| +2% | +$484K | 1.02% | 27 |
|
|
2023
Q2 | $20M | Buy |
148,565
+7,907
| +6% | +$1.16M | 0.87% | 35 |
|
|
2023
Q1 | $22.4M | Buy |
140,658
+39,840
| +40% | +$6.09M | 1% | 30 |
|
|
2022
Q4 | $16.3M | Sell |
100,818
-8,921
| -8% | -$1.37M | 0.73% | 46 |
|
|
2022
Q3 | $14.7M | Buy |
109,739
+33,673
| +44% | +$4.83M | 0.74% | 45 |
|
|
2022
Q2 | $11.7M | Sell |
76,066
-2,368
| -3% | -$362K | 0.56% | 56 |
|
|
2022
Q1 | $12.7M | Sell |
78,434
-6,851
| -8% | -$995K | 0.53% | 58 |
|
|
2021
Q4 | $11.5M | Sell |
85,285
-16,698
| -16% | -$1.97M | 0.45% | 64 |
|
|
2021
Q3 | $11M | Sell |
101,983
-5,775
| -5% | -$660K | 0.46% | 62 |
|
|
2021
Q2 | $12.1M | Sell |
107,758
-11,248
| -9% | -$1.27M | 0.51% | 61 |
|
|
2021
Q1 | $12.9M | Sell |
119,006
-30,965
| -21% | -$3.31M | 0.56% | 51 |
|
|
2020
Q4 | $16.1M | Sell |
149,971
-11,740
| -7% | -$1.13M | 0.75% | 42 |
|
|
2020
Q3 | $14.2M | Sell |
161,711
-32,680
| -17% | -$3.08M | 0.74% | 43 |
|
|
2020
Q2 | $19.1M | Sell |
194,391
-11,512
| -6% | -$1.01M | 1.07% | 26 |
|
|
2020
Q1 | $15.7M | Sell |
205,903
-17,746
| -8% | -$1.51M | 0.99% | 27 |
|
|
2019
Q4 | $19.8M | Sell |
223,649
-13,541
| -6% | -$1.12M | 1.01% | 29 |
|
|
2019
Q3 | $18M | Sell |
237,190
-68,495
| -22% | -$4.7M | 0.98% | 33 |
|
|
2019
Q2 | $22.2M | Buy |
305,685
+5,472
| +2% | +$430K | 1.21% | 23 |
|
|
2019
Q1 | $24.2M | Buy |
300,213
+14,906
| +5% | +$1.22M | 1.36% | 22 |
|
|
2018
Q4 | $26.3M | Buy |
285,307
+15,569
| +6% | +$1.37M | 1.63% | 18 |
|
|
2018
Q3 | $25.5M | Buy |
269,738
+5,245
| +2% | +$497K | 1.4% | 23 |
|
|
2018
Q2 | $24.5M | Buy |
264,493
+6,583
| +3% | +$643K | 1.41% | 24 |
|
|
2018
Q1 | $24.4M | Sell |
257,910
-18,426
| -7% | -$2.02M | 1.42% | 23 |
|
|
2017
Q4 | $26.7M | Sell |
276,336
-14,447
| -5% | -$1.36M | 1.49% | 21 |
|
|
2017
Q3 | $25.8M | Sell |
290,783
-1,548
| -0.5% | -$118K | 1.48% | 23 |
|
|
2017
Q2 | $21.2M | Buy |
292,331
+6,916
| +2% | +$465K | 1.26% | 29 |
|
|
2017
Q1 | $18.6M | Buy |
285,415
+13,007
| +5% | +$818K | 1.12% | 32 |
|
|
2016
Q4 | $17.1M | Buy |
272,408
+19,902
| +8% | +$1.21M | 1.04% | 32 |
|
|
2016
Q3 | $15.9M | Sell |
252,506
-2,517
| -1% | -$163K | 1.01% | 32 |
|
|
2016
Q2 | $15.8M | Buy |
255,023
+16,095
| +7% | +$981K | 1.01% | 32 |
|
|
2016
Q1 | $13.6M | Buy |
238,928
+22,356
| +10% | +$1.25M | 0.9% | 36 |
|
|
2015
Q4 | $12.8M | Buy |
216,572
+31,941
| +17% | +$1.84M | 0.87% | 36 |
|
|
2015
Q3 | $10M | Buy |
184,631
+17,161
| +10% | +$1.12M | 0.72% | 40 |
|
|
2015
Q2 | $11.3M | Sell |
167,470
-1,224
| -0.7% | -$79.9K | 0.77% | 37 |
|
|
2015
Q1 | $9.88M | Sell |
168,694
-8,234
| -5% | -$497K | 0.67% | 43 |
|
|
2014
Q4 | $11.6M | Sell |
176,928
-3,360
| -2% | -$212K | 0.77% | 38 |
|
|
2014
Q3 | $10.4M | Buy |
180,288
+456
| +0.3% | +$25.3K | 0.76% | 38 |
|
|
2014
Q2 | $10.1M | Sell |
179,832
-12,021
| -6% | -$631K | 0.7% | 41 |
|
|
2014
Q1 | $9.86M | Sell |
191,853
-48,568
| -20% | -$2.45M | 0.7% | 41 |
|
|
2013
Q4 | $12.7M | Sell |
240,421
-6,299
| -3% | -$310K | 0.9% | 31 |
|
|
2013
Q3 | $11M | Buy |
246,720
+1,371
| +0.6% | +$60.8K | 0.84% | 34 |
|
|
2013
Q2 | $10.1M | Buy |
+245,349
| New | +$10.7M | 0.82% | 35 |
|
Other funds holding ABBV
Park National Corp's ABBV Position: Q2 2026 in Review
Park National Corp reduced its AbbVie (ABBV) stake by 2.1% in Q2 2026, selling an estimated $478K and leaving 103,283 shares worth $26M. The position accounts for 0.73% of the portfolio, ranked #41.
Park National Corp first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $27.4M in Q3 2024. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Park National Corp held 103,283 shares of AbbVie worth $26M as of Q2 2026.
- Park National Corp sold 2,223 AbbVie shares in Q2 2026, an estimated $478K.
- AbbVie made up 0.73% of Park National Corp's portfolio in Q2 2026, its #41 holding.
- Park National Corp first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Park National Corp's AbbVie position peaked at $27.4M in Q3 2024.
- 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Park National Corp's 13F filing for Q2 2026, filed 15 Jul 2026.